Trexquant Investment LP Chimerix Inc Transaction History

Trexquant Investment LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$5.94 - $8.75 $66,290 - $97,650	-11,160 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$7.54 - $9.79 $84,146 - $109,256	11,160 New	11,160 $89,000
Q3 2018 Nov 09, 2018	SELL	$3.58 - $4.9 $58,862 - $80,565	-16,442 Closed	0 $0
Q2 2018 Aug 07, 2018	BUY	$4.43 - $5.14 $19,872 - $23,058	4,486 Added 37.52%	16,442 $78,000
Q1 2018 May 03, 2018	SELL	$4.65 - $5.9 $25,635 - $32,526	-5,513 Reduced 31.56%	11,956 $62,000
Q4 2017 Feb 09, 2018	BUY	$4.32 - $5.52 $75,466 - $96,428	17,469	17,469 $81,000

36.8M

72.2K

169K

Ticker CMRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,622,896
Market Cap $85M
Description
Chimerix, Inc., a biopharmaceutical company, develops medicines to enhance the lives of patients living with serious diseases. The company's approved product is TEMBEXA (brincidofovir), a lipid conjugate through inhibition of viral DNA synthesis that is developed as a medical countermeasure for smallpox. Its clinical stage development programs i...

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

Stay updated on Trexquant Investment LP with notifications on news.